Skip to main content

Advertisement

Correction to: Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trial

The original article was published in Trials 2018 19:670

Correction to: Trials (2018) 19:670

https://doi.org/10.1186/s13063-018-3050-4

After publication of the original article [1], the authors notified that that one of the BNTRC institutional collaborator names was misspelled. Both incorrect and correct spellings are presented below.

  • Originally published name

Ardalan Zolnouria

  • Correct name spelling

Ardalan Zolnourian

Reference

  1. 1.

    Kolias AG, et al. Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trial. Trials. 2018;19:670. https://doi.org/10.1186/s13063-018-3050-4.

Download references

Author information

Correspondence to Angelos G. Kolias or Ellie Edlmann or Peter J. Hutchinson.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.